Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience

(2013) D. Laharie et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Infliximab in Steroid-dependent Ulcerative Colitis

(2013) Alessandro Armuzzi et al.   INFLAMMATORY BOWEL DISEASES

Recommendations for identifying Crohn’s disease patients with poor prognosis

(2012) Pal Miheller et al.   Expert Review of Clinical Immunology

Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus

(2012) Walter Reinisch et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis

(2009) Manuel Barreiro-de Acosta et al.   Journal of Crohns & Colitis

Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis

(2008) Wulfran Cacheux et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-term outcome after infliximab for refractory ulcerative colitis

(2008) Marc Ferrante et al.   Journal of Crohns & Colitis

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET